Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung diseases in pregnancy

E W Russi1

  • 1Abteilung für Pneumologie, Universitätsspital Zürich.

Schweizerische Medizinische Wochenschrift
|November 14, 1997
PubMed
Summary

Pregnant patients often experience shortness of breath due to physiological changes. While most lung diseases are similar, drug treatments require special consideration for the fetus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline.

Occupational and environmental medicine·2013
Same author

[Dyspnoea, cough and B symptoms in a 40-year-old woman].

Der Internist·2013
Same author

Diagnosis and management of chronic obstructive pulmonary disease: the Swiss guidelines. Official guidelines of the Swiss Respiratory Society.

Respiration; international review of thoracic diseases·2013
Same author

Prevalence and prediction of exercise-induced oxygen desaturation in patients with chronic obstructive pulmonary disease.

Respiration; international review of thoracic diseases·2012
Same author

Prevalence of airflow obstruction in smokers and never-smokers in Switzerland.

The European respiratory journal·2010
Same author

HMOX1 and GST variants modify attenuation of FEF25-75% decline due to PM10 reduction.

The European respiratory journal·2010

Area of Science:

  • Obstetrics and Gynecology
  • Pulmonology
  • Clinical Medicine

Background:

  • Pregnancy involves significant physiological changes impacting cardiopulmonary function.
  • Respiratory complaints are common in pregnant individuals, with shortness of breath being the most prevalent symptom.
  • Understanding these changes is crucial for managing respiratory conditions during pregnancy.

Purpose of the Study:

  • To review the clinical and cardiopulmonary manifestations of diseases in pregnant patients.
  • To highlight the necessary physiological knowledge for managing these conditions.
  • To discuss the unique considerations for pharmacotherapy in pregnant patients.

Main Methods:

  • Literature review of physiological changes during pregnancy.
  • Analysis of common respiratory conditions in pregnant women.
  • Examination of diagnostic and therapeutic approaches, including pharmacotherapy.

Main Results:

  • Shortness of breath is often due to physiological gestational hyperventilation.
  • Conditions like bronchial asthma occur with similar prevalence in pregnant and non-pregnant individuals.
  • Standard clinical management, diagnosis, and treatment generally apply, with pharmacotherapy requiring special attention.

Conclusions:

  • Physicians must understand pregnancy-related physiological changes to manage respiratory complaints effectively.
  • Pharmacotherapy during pregnancy necessitates careful consideration of maternal pharmacokinetics and potential fetal exposure.
  • Effective management balances maternal health with fetal safety.

Related Experiment Videos